Hydroxyurea for β-thalassaemia major

Saqib H. Ansari; Zohra S. Lassi; Salima M. Ali; Syed Omair Adil; Tahir S. Shamsi

doi:10.1002/14651858.CD012064

Hydroxyurea for β-thalassaemia major

Saqib H. Ansari, Zohra S. Lassi, Salima M. Ali, Syed Omair Adil, Tahir S. Shamsi

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: The primary objective is to review the safety of hydroxyurea with regards to severe adverse effects in people with β-thalassaemia major. The second objective is to review the efficacy of hydroxyurea in reducing or ameliorating the requirement of blood transfusions in people with β-thalassaemia major.

Original language	English
Article number	CD012064
Journal	Cochrane Database of Systematic Reviews
Volume	2016
Issue number	1
DOIs	https://doi.org/10.1002/14651858.CD012064
Publication status	Published or Issued - 29 Jan 2016
Externally published	Yes

ASJC Scopus subject areas

Pharmacology (medical)

Access to Document

10.1002/14651858.CD012064

Cite this

@article{c167b74be2964e77bb4a976c818634f0,

title = "Hydroxyurea for β-thalassaemia major",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: The primary objective is to review the safety of hydroxyurea with regards to severe adverse effects in people with β-thalassaemia major. The second objective is to review the efficacy of hydroxyurea in reducing or ameliorating the requirement of blood transfusions in people with β-thalassaemia major.",

author = "Ansari, {Saqib H.} and Lassi, {Zohra S.} and Ali, {Salima M.} and Adil, {Syed Omair} and Shamsi, {Tahir S.}",

note = "Publisher Copyright: {\textcopyright} 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",

year = "2016",

month = jan,

day = "29",

doi = "10.1002/14651858.CD012064",

language = "English",

volume = "2016",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "1",

}

TY - JOUR

T1 - Hydroxyurea for β-thalassaemia major

AU - Ansari, Saqib H.

AU - Lassi, Zohra S.

AU - Ali, Salima M.

AU - Adil, Syed Omair

AU - Shamsi, Tahir S.

PY - 2016/1/29

Y1 - 2016/1/29

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: The primary objective is to review the safety of hydroxyurea with regards to severe adverse effects in people with β-thalassaemia major. The second objective is to review the efficacy of hydroxyurea in reducing or ameliorating the requirement of blood transfusions in people with β-thalassaemia major.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: The primary objective is to review the safety of hydroxyurea with regards to severe adverse effects in people with β-thalassaemia major. The second objective is to review the efficacy of hydroxyurea in reducing or ameliorating the requirement of blood transfusions in people with β-thalassaemia major.

UR - http://www.scopus.com/inward/record.url?scp=84969497672&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD012064

DO - 10.1002/14651858.CD012064

M3 - Article

AN - SCOPUS:84969497672

SN - 1465-1858

VL - 2016

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 1

M1 - CD012064

ER -

Hydroxyurea for β-thalassaemia major

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this